Stebėti
Nina Miazek-Zapala
Nina Miazek-Zapala
Medical University of Warsaw, World Hearing Center
Patvirtintas el. paštas wum.edu.pl
Pavadinimas
Cituota
Cituota
Metai
Pityriasis alba—common disease, enigmatic entity: up‐to‐date review of the literature
N Miazek, I Michalek, M Pawlowska‐Kisiel, M Olszewska, L Rudnicka
Pediatric dermatology 32 (6), 786-791, 2015
812015
HDAC6 inhibition upregulates CD20 levels and increases the efficacy of anti-CD20 monoclonal antibodies
M Bobrowicz, M Dwojak, B Pyrzynska, J Stachura, A Muchowicz, ...
Blood, The Journal of the American Society of Hematology 130 (14), 1628-1638, 2017
502017
B-cell receptor signaling in the pathogenesis of lymphoid malignancies
K Bojarczuk, M Bobrowicz, M Dwojak, N Miazek, P Zapala, A Bunes, ...
Blood Cells, Molecules, and Diseases 55 (3), 255-265, 2015
432015
Inhibition of thioredoxin-dependent H2O2 removal sensitizes malignant B-cells to pharmacological ascorbate
A Graczyk-Jarzynka, A Goral, A Muchowicz, R Zagozdzon, M Winiarska, ...
Redox biology 21, 101062, 2019
322019
FOXO1 promotes resistance of non-Hodgkin lymphomas to anti-CD20-based therapy
B Pyrzynska, M Dwojak, A Zerrouqi, G Morlino, P Zapala, N Miazek, ...
Oncoimmunology 7 (5), e1423183, 2018
312018
Inhibitors of SRC kinases impair antitumor activity of anti-CD20 monoclonal antibodies
M Winiarska, K Bojarczuk, B Pyrzynska, J Bil, M Siernicka, M Dwojak, ...
MAbs 6 (5), 1300-1313, 2014
212014
Catheter-associated bacterial flora in patients with benign prostatic hyperplasia: shift in antimicrobial susceptibility pattern
BA Dybowski, P Zapała, E Bres-Niewada, Ł Zapała, N Miązek-Zapała, ...
BMC Infectious Diseases 18, 1-7, 2018
152018
Open partial nephrectomy for entirely intraparenchymal tumors: a matched case-control study of oncologic outcome and complication rate
P Zapala, B Dybowski, N Miazek, P Radziszewski
International braz j urol 43, 209-215, 2017
152017
Influence of left atrial size on the outcome of pulmonary vein isolation in patients with atrial fibrillation
M Kiliszek, N Miązek, M Peller, S Gajda, E Koźluk, P Lodziński, ...
Kardiologia Polska (Polish Heart Journal) 72 (11), 1135-1140, 2014
92014
Selective inhibition of HDAC6 sensitizes cutaneous T‑cell lymphoma to PI3K inhibitors
M Bobrowicz, A Slusarczyk, J Domagala, M Dwojak, D Ignatova, ...
Oncology letters 20 (1), 533-540, 2020
72020
The “Magic Bullet” Is Here? Cell-Based Immunotherapies for Hematological Malignancies in the Twilight of the Chemotherapy Era
N Miazek-Zapala, A Slusarczyk, A Kusowska, P Zapala, M Kubacz, ...
Cells 10 (6), 1511, 2021
42021
A stone pushed back to the collecting system–long therapeutic path in centers with limited access to flexible instruments
E Bres-Niewada, B Dybowski, P Zapała, S Poletajew, N Miązek-Zapała, ...
Central European Journal of Urology 71 (2), 186, 2018
12018
Inhibitors of Src family and AKT regulate the activity of CD20 promoter
B Pyrzynska, K Bojarczuk, M Winiarska, J Bil, N Miazek, P Zapala, ...
Blood 122 (21), 1838, 2013
12013
Natural killer immune response is promoted by the treatment of B-cell lymphoma cancer cells with membrane ionophores.
A Zerrouqi, A Torun, N Miazek, Z Pilch, J Golab, B Pyrzynska
CANCER IMMUNOLOGY RESEARCH 8 (3), 92-93, 2020
2020
Abstract B14: Natural killer immune response is promoted by the treatment of B-cell lymphoma cancer cells with membrane ionophores
A Zerrouqi, A Torun, N Miazek, Z Pilch, J Golab, B Pyrzynska
Cancer Immunology Research 8 (3_Supplement), B14-B14, 2020
2020
Salinomycin expands the cytotoxicity of both anti-CD20 monoclonal antibodies and natural killer cells towards non-Hodgkin lymphomas
A Zerrouqi, N Miazek-Zapala, A Torun, P Zapala, J Golab, M Winiarska, ...
CANCER RESEARCH 79 (13), 2019
2019
Abstract LB-261: Salinomycin expands the cytotoxicity of both anti-CD20 monoclonal antibodies and natural killer cells towards non-Hodgkin lymphomas
A Zerrouqi, N Miazek-Zapala, A Torun, P Zapala, J Golab, M Winiarska, ...
Cancer Research 79 (13_Supplement), LB-261-LB-261, 2019
2019
Selective inhibition of HDAC6 sensitizes CTCL to PI3K inhibitors
M Bobrowicz, J Stachura, M Dwojak, D Ignatova, YT Chang, C Iselin, ...
European Journal of Cancer 119, S37, 2019
2019
Abstract B27: B-cell lymphoma response to anti-CD20 antibodies based therapies is tightly modulated by FOXO1-mediated MS4A1 gene transcription
A Zerrouqi, B Pyrzynska, M Dwojak, N Miazek, P Zapala, J Golab, ...
Cancer Immunology Research 6 (9_Supplement), B27-B27, 2018
2018
FOXO1 is transcriptional regulator of malignant B-cell surface antigen CD20, the target for therapeutic monoclonal antibodies
B Pyrzynska, A Zerrouqi, M Dwojak, G Morlino, P Zapala, N Miazek, ...
CANCER IMMUNOLOGY RESEARCH 6 (9), 2018
2018
Sistema negali atlikti operacijos. Bandykite vėliau dar kartą.
Straipsniai 1–20